In a major step forward for cancer treatment, researchers have developed a new type of “smart” chemical that attacks ...

A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ ...

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S.

Telomir-1 reduced tumor size by 50% in a prostate cancer model and protected against chemotherapy ... tumor development…We are seeing a drug that extends cellular health while simultaneously ...

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease ...

City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting transcription-replication conflicts to combat treatment resistance.

Each patient’s cancer is a unique mosaic of genetic ... forward both with a synergistic diagnostic and a drug development model. You can do that when you have a company built on experience ...

A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing ...

Contrary to concerns that telomere-elongating drugs may promote cancer, Telomir-1 demonstrated the opposite effect—actively suppressing tumor development, while selectively benefiting healthy cells.

New findings may help patients with low to moderate risk of tumor lysis syndrome while reducing the burden for hematologists.

Researchers have identified a new molecular target for treating pancreatic cancer. Scientists focused on transcription-replication conflicts (TRCs), which occur when the mechanisms responsible for ...

The model harnesses whole-slide tumor imaging data and gene ... “Perhaps an abundance of fibroblasts can shield tumor cells from chemotherapeutic drugs or support cancer cell growth. I would like to ...